Novel approaches to support therapeutic development in ultra-rare cancers
Per-recipient award not stated for city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, private institutions of higher education, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, special district governments, state governments.
City or township governmentsCounty governmentsFor profit organizations other than small businessesIndependent school districtsNative American tribal governments (Federally recognized)Native American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationPublic and State controlled institutions of higher educationPublic housing authorities/Indian housing authoritiesSmall businessesSpecial district governmentsState governmentsAgricultureConsumer ProtectionFood & Nutrition
In one sentence
Novel approaches to support therapeutic development in ultra-rare cancers does not state a per-recipient award amount, open to city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments…
Record fields
- Program pool (total)
- Not confirmedTotal across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- Not confirmed
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Not stated
- Deadline type
- Not stated
- Opens
- Not stated
- Status
- Forecasted
- Eligible entities
- City or township governments · County governments · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · State governments
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- Development of infrastructure for coordination networks and data repositories for ultra-rare cancers · Exploration of early clinical endpoints and novel efficacy endpoints for ultra-rare cancer treatments · Development of multi-stakeholder collaborative efforts using real-world data registries for pediatric diffuse midline glioma · Identification of opportunities for clinical development of previously approved drugs in ultra-rare cancers · Research on preservation of drug availability for discontinued development in ultra-rare cancers · Development of telemedicine and pragmatic trial design methods for ultra-rare cancer patient enrollment · Development of nanoparticle-based delivery approaches for therapeutic nucleic acids targeting onco-fusion transcription factors · Characterization of plasma-membrane protein expression in ultra-rare cancers
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Program pool (total)Across all awards this cycle
Not statedAward ceiling (per project)The most one applicant can receive
Not statedWho can apply?
level
Derived from the source that published this record
entity
City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Public and State controlled institutions of higher education
Source field: entity types+4more
, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governmentsindustry
Source field: industries
use
Characterization of plasma-membrane protein expression in ultra-rare cancers, Development of infrastructure for coordination networks and data repositories for ultra-rare cancers, Development of multi-stakeholder collaborative efforts using real-world data registries for pediatric diffuse midline glioma, Development of nanoparticle-based delivery approaches for therapeutic nucleic acids targeting onco-fusion transcription factors, Development of telemedicine and pragmatic trial design methods for ultra-rare cancer patient enrollment, Exploration of early clinical endpoints and novel efficacy endpoints for ultra-rare cancer treatments, Identification of opportunities for clinical development of previously approved drugs in ultra-rare cancers, Research on preservation of drug availability for discontinued development in ultra-rare cancers
Source field: use of fundssize limit
Not confirmed
Source field: applicant size limitclause text
Not confirmed
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
Not statedDeadline type Not stated
What can the money be used for?
8 categorysThe source’s own spending categories, and what is not parsed.
Development of infrastructure for coordination networks and data repositories for ultra-rare cancersExploration of early clinical endpoints and novel efficacy endpoints for ultra-rare cancer treatmentsDevelopment of multi-stakeholder collaborative efforts using real-world data registries for pediatric diffuse midline gliomaIdentification of opportunities for clinical development of previously approved drugs in ultra-rare cancersResearch on preservation of drug availability for discontinued development in ultra-rare cancersDevelopment of telemedicine and pragmatic trial design methods for ultra-rare cancer patient enrollmentDevelopment of nanoparticle-based delivery approaches for therapeutic nucleic acids targeting onco-fusion transcription factorsCharacterization of plasma-membrane protein expression in ultra-rare cancers
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
Common questions
3 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- Who is eligible to apply?
- City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments.
- What can the funding be used for?
- Development of infrastructure for coordination networks and data repositories for ultra-rare cancers, Exploration of early clinical endpoints and novel efficacy endpoints for ultra-rare cancer treatments, Development of multi-stakeholder collaborative efforts using real-world data registries for pediatric diffuse midline glioma, Identification of opportunities for clinical development of previously approved drugs in ultra-rare cancers, Research on preservation of drug availability for discontinued development in ultra-rare cancers, Development of telemedicine and pragmatic trial design methods for ultra-rare cancer patient enrollment, Development of nanoparticle-based delivery approaches for therapeutic nucleic acids targeting onco-fusion transcription factors, Characterization of plasma-membrane protein expression in ultra-rare cancers, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inProvenance
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.